StocksFin Logo
FOLD logo
$FOLD

Amicus Therapeutics, Inc.

FOLD country of incorporation
|
https://amicusrx.com
|
Mr. John Crowley
|
496 employees
NASDAQ | Healthcare | Biotechnology
FOLD reported its Q322 earnings on November 7, 2022 (76 weeks ago).
$81.69M 2.7% vs. Q321 Revenues Q322
83.55% -2% vs. Q321 Gross Profit Margin
-40.75% ! 35.6% vs. Q321 Net Profit Margin
-11.49M ! 53.3% vs. Q321 Free Cash Flow Q322
$-0.12 ! 36.8% vs. Q321 EPS Q322
Company Card Q322
As reported on November 7, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Company Card Q322
As reported on November 7, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
81.69M
+1.2%
13.44M
-33.29M
+46.4%
$-0.12
Q22022
80.73M
+2.6%
8.2M
-62.16M
+27.1%
$-0.21
Q12022
78.72M
7.58M
-85.26M
$-0.3
FY2021
305.51M
 34.47M
-250.46M
$-0.92
Q42021
82.15M
+3.3%
7.85M
-83.28M
-65.6%
$-0.24
Q32021
79.55M
+2.8%
11.7M
-50.29M
+1.8%
$-0.19
Q22021
77.41M
+16.6%
8.38M
-51.23M
+22%
$-0.19
Q12021
66.4M
6.54M
-65.66M
$-0.25
FY2020
260.89M
 31.04M
-276.85M
$-1.07
FY2019
182.24M
 21.96M
-356.39M
$-1.48
FY2018
91.25M
 14.4M
-349M
$-1.88
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
759.53M
 626.96M
277.59M
450.87M
132.57M
Q22022
800.59M
 627.16M
235.64M
451.04M
173.43M
Q12022
826.94M
 588.32M
233.32M
447.71M
238.62M
FY2021
905.14M
 597.77M
245.2M
447.54M
307.37M
FY2020
886.52M
 600.14M
163.24M
403M
286.38M
FY2019
850.21M
 373.78M
142.84M
163.88M
476.43M
FY2018
789.95M
 447.04M
79.75M
321.74M
342.91M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
-11.63M
 74.52M
-559k
0
-11.49M
+29.2%
Q22022
-15.86M
 26.29M
693k
-355k
-16.22M
+72.6%
Q12022
-58.32M
 58.21M
-8.15M
-871k
-59.19M
FY2021
-202.49M
 78.76M
212.07M
-3.88M
-206.38M
FY2020
-233.29M
 -13.58M
262.86M
-3.23M
-236.52M
FY2019
-250.42M
 95.15M
217.5M
-20.01M
-270.43M
FY2018
-299.96M
 -121.2M
450.78M
-6.31M
-306.26M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees